SCHEMBL29702425

SCHEMBL29702425

O=c1[nH]ncc2cc(O[C@H]3CCOC3)ccc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK1 Q13464 11/20 0.43
ROCK2 O75116 2/20 0.43
PRKCD Q05655 2/20 0.43
PRKACA P17612 1/20 0.43
PRKG1 Q13976 1/20 0.43
PKN1 Q16512 1/20 0.43
PKN2 Q16513 1/20 0.43
AAK1 Q2M2I8 1/20 0.43
CDC42BPA Q5VT25 1/20 0.43
Q6ZSR9 Q6ZSR9 1/20 0.43
BMP2K Q9NSY1 1/20 0.43
CDC42BPB Q9Y5S2 1/20 0.43
ALK Q9UM73 1/20 0.42
LRRK2 Q5S007 4/20 0.40
PRKX P51817 1/20 0.40
PRKCE Q02156 1/20 0.40
PRKD1 Q15139 1/20 0.40
ALDH1A1 P00352 1/20 0.39
PARP1 P09874 1/20 0.39
PRKCI P41743 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5413256 0.83 ROCK2 (0.52) ROCK1ROCK2PRKG1PKN2LRRK2
SCHEMBL30544659 0.81 ACACB (0.38) LRRK2GRM4
SCHEMBL29702357 0.79 ROCK1 (0.66) ROCK1ROCK2PRKCDPRKACAPRKG1
SCHEMBL30544671 0.78 PDE4D (0.45) PDE4B
SCHEMBL29058957 0.78 PDE4D (0.45) PDE4B
SCHEMBL29058960 0.78 PDE4D (0.45) PDE4B
SCHEMBL29702396 0.76 ALK (0.41) ALKLRRK2
SCHEMBL5409080 0.75 ROCK2 (0.57) ROCK1ROCK2PRKG1PKN2LRRK2
SCHEMBL6584281 0.73 PDE4D (0.52) ALDH1A1PDE4BHSD17B10
SCHEMBL1009542 0.71 HSD17B10 (0.51) ROCK2ALDH1A1PARP1PRKCIPDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116635371-A Polycyclic pyridazinone derivative serving as SOS1 inhibitor, and preparation method and application thereof 苏州阿尔脉生物科技有限公司 2023-08-22 CN disclosed
CN-114621186-A Heterocyclic compounds as modulators of RAS signaling pathway 上海维申医药有限公司 2022-06-14 CN disclosed